Global Cell and Gene Therapy Manufacturing Services Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Cell and Gene Therapy Manufacturing Services Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Service Type (Cell Therapy (Allogeneic, Autologous, Viral Vector), and Gene Therapy (Non-viral Vectors, and Viral Vectors)), Application (Clinical Manufacturing, and Commercial Manufacturing), Indication (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Infectious Diseases, and Other Indications), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End Users), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Cell and Gene Therapy Manufacturing Services Market was valued at USD 9,218.8 million in 2023 and is expected to reach USD 60,833.4 million by 2031 while growing at a CAGR of 26.6% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global cell and gene therapy manufacturing services market growth. Cell and gene therapy manufacturing services are specialized offerings by contract manufacturing organizations (CMOs) or other providers. They assist in developing, producing, and commercializing therapies that use living cells or genetic material to treat diseases. Due to the complexity of the manufacturing process, which demands specialized expertise and facilities, many biopharmaceutical companies may lack these capabilities in-house.
The Cell and Gene Therapy Manufacturing Services market is expected to grow significantly due to the rising prevalence of genetic disorders and chronic diseases. However, challenges like high manufacturing costs and strict regulatory requirements may hinder market expansion.
Furthermore, the global cell and gene therapy manufacturing services industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Service Type Analysis
The Global Cell and Gene Therapy Manufacturing Services Market is segmented among Cell Therapy, and Gene Therapy, based on Service Type. In 2023, Cell Therapy accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Application Analysis
The Global Cell and Gene Therapy Manufacturing Services Market is segmented among Clinical Manufacturing, and Commercial Manufacturing, based on Application. In 2023, Clinical Manufacturing accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Cell and Gene Therapy Manufacturing Services Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Catalent Inc., Cell and Gene Therapy Catapult, Charles River Laboratories, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, Lonza, Merck KGaA, Nikon CeLL innovation Co. Ltd, Oxford Biomedica PLC, and Takara Bio Inc.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Cell and Gene Therapy Manufacturing Services Market Dynamics
Drivers
Restraints
Opportunity
4. Global Cell and Gene Therapy Manufacturing Services Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Cell and Gene Therapy Manufacturing Services Market Segmentation, By Service Type
Global Cell and Gene Therapy Manufacturing Services Market Share Analysis, By Service Type
Global Cell and Gene Therapy Manufacturing Services Market Growth Analysis, By Service Type
Global Cell and Gene Therapy Manufacturing Services Market Trends, By Service Type
o Cell Therapy
Ø Allogeneic
Ø Autologous
Ø Viral Vector
o Gene Therapy
Ø Non-viral Vectors
Ø Viral Vectors
6. Global Cell and Gene Therapy Manufacturing Services Market Segmentation, By Application
Global Cell and Gene Therapy Manufacturing Services Market Share Analysis, By Application
Global Cell and Gene Therapy Manufacturing Services Market Growth Analysis, By Application
Global Cell and Gene Therapy Manufacturing Services Market Trends, By Application
o Clinical Manufacturing
o Commercial Manufacturing
7. Global Cell and Gene Therapy Manufacturing Services Market Segmentation, By Indication
Global Cell and Gene Therapy Manufacturing Services Market Share Analysis, By Indication
Global Cell and Gene Therapy Manufacturing Services Market Growth Analysis, By Indication
Global Cell and Gene Therapy Manufacturing Services Market Trends, By Indication
o Oncology
o Cardiovascular Diseases
o Orthopedic Diseases
o Infectious Diseases
o Other Indications
8. Global Cell and Gene Therapy Manufacturing Services Market Segmentation, By End User
Global Cell and Gene Therapy Manufacturing Services Market Share Analysis, By End User
Global Cell and Gene Therapy Manufacturing Services Market Growth Analysis, By End User
Global Cell and Gene Therapy Manufacturing Services Market Trends, By End User
o Pharmaceutical and Biotechnology Companies
o Academic and Research Institutes
o Other End Users
9. Global Cell and Gene Therapy Manufacturing Services Market Segmentation, By Region
Global Cell and Gene Therapy Manufacturing Services Market Share Analysis, By Region
Global Cell and Gene Therapy Manufacturing Services Market Growth Analysis, By Region
Global Cell and Gene Therapy Manufacturing Services Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
10. Competitive Landscape
Catalent Inc.*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Cell and Gene Therapy Catapult
Charles River Laboratories
F. Hoffmann-La Roche Ltd
Fujifilm Holdings Corporation
Lonza
Merck KGaA
Nikon CeLL innovation Co. Ltd
Oxford Biomedica PLC
Takara Bio Inc.
*Similar analysis will be provided for each company listed above.